Clinical Trials

Clinical Trial Detail

Return to search results.

Human Papillomavirus (HPV) or Pap Examination (HOPE) Study

Complete title: Cytology vs. at Home HPV Screening for Detection of CIN 2,3,CIS

Research Study Number       7489
Principal Investigator       Nancy Kiviat, MD
Phase       NA

Look up trial at NIH

Research Study Description

This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.

Eligibility Criteria (must meet the following to participate in this study)

Ages Eligible for Study: 21 Years and older

Genders Eligible for Study: Female

- Able to provide informed consent in English

Other eligibility criteria may apply.

Exclusions (conditions that would prevent participation in this study)

- Have had hysterectomy

- Currently pregnant

- Received treatment of cervical dysplasia with loop electrosurgical excision procedure (LEEP), cone biopsy, laser procedure or cryotherapy within THREE years

- Received colposcopy of cervix within TWO years

- Received Pap test within ONE year

- Immunocompromised (positive human immunodeficiency virus [HIV] test, transplant recipient, received chemotherapy for cancer, or taking immunosuppressant drugs)

- Decisionally impaired adults requiring a legally authorized representative

Other exclusion criteria may apply.

Research Study Number       7489
Contact       Cady Stanton
Telephone       206/543-3327

Cervical Cancer; Gynecological Cancer; Solid Tumors; Uterine Cancer

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials